A 22-year-old healthy man was admitted for oedema 15 days after the first injection of the COVISHIELD coronavirus disease 2019 (COVID-19) vaccine (Oxford AstraZeneca) vaccine. Nephrotic syndrome was diagnosed and a kidney biopsy showed minimal change disease. Oral prednisolone was started at 1 mg/kg/day resulting in complete remission within 1 week.
Keywords: COVID-19 vaccine; COVISHIELD; minimal change disease; nephrotic syndrome; steroids.
© The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA.